The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 05, 2023

Filed:

Oct. 29, 2020
Applicant:

Medtronic, Inc., Minneapolis, MN (US);

Inventors:

Michael E. Winek, Minneapolis, MN (US);

Lauren E. Barth, Minneapolis, MN (US);

Assignee:

MEDTRONIC, INC., Minneapolis, MN (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 5/142 (2006.01); A61M 5/172 (2006.01); A61M 5/168 (2006.01); A61M 5/158 (2006.01); A61M 25/00 (2006.01); A61M 27/00 (2006.01);
U.S. Cl.
CPC ...
A61M 5/14276 (2013.01); A61M 5/14212 (2013.01); A61M 5/1582 (2013.01); A61M 5/16809 (2013.01); A61M 5/172 (2013.01); A61M 25/0026 (2013.01); A61M 27/006 (2013.01); A61M 2005/14208 (2013.01); A61M 2205/3553 (2013.01); A61M 2205/52 (2013.01);
Abstract

Intrathecal drug delivery pumps can aspirate cerebrospinal fluid (CSF) when the drug reservoir is empty or at other times to maintain a continuous or cyclic fluid flow through the pump and the delivery catheter. This addresses the potential need for continuous infusion to maintain an un-occluded fluid pathway to the intrathecal space by providing an 'active port' that aspirates and expels CSF to keep fluid flow going without infusing a drug or requiring saline to fill the pump. If drug refill visits are missed, CSF could be used to keep the pump mechanism functional rather than having it run dry requiring replacement or requiring saline injections to keep the pump mechanism functioning. In addition, by having the pump aspirate CSF into the body of the pump, it would be possible to monitor biomarkers using systems in the fluid pathway and pressure differences for possible issues related to CSF management.


Find Patent Forward Citations

Loading…